Source - Alliance News

Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Partners with Kelowna General Hospital in Canada for a pilot program to prevent hospital-acquired infections using its Steriwave nasal photodisinfection therapy. Says Steriwave is already in use at a number of hospitals acrsoss Canada.

Chief Executive Officer Carolyn Cross says: ‘We believe that every patient deserves the best protection against HAIs. By wiping out the pathogens in the nose, which is a major reservoir for these potentially fatal pathogens, our photodisinfection treatment can reduce HAIs following major surgeries by up to 80%.’

Current stock price: 16.23 pence, up 1.4% on Monday

12-month change: down 58%

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Ondine Biomedical Inc. (OBI)

0p (0.00%)
delayed 15:49PM